Susan Collins, the Maine Republican, got straight to the point in describing the new Senate health care bill: “Still deep cuts to Medicaid in Senate bill. Will vote no,” she tweeted yesterday. “Ready to work w/ GOP & Dem colleagues to fix flaws in ACA.”
Rob Portman, the Ohio Republican and another potential swing vote, was less straightforward. “I opposed the last draft of the Senate health proposal because I had concerns about the measure’s Medicaid policies,” Portman said in a statement. Later, he followed up saying that he was undecided about whether he would support this bill.
Here’s the problem for Portman: Collins is right. The Medicaid policies are virtually identical between the revised Senate bill and the previous bill. If Portman opposed the last bill because of how it would harm Medicaid recipients — and he did — he would logically need to oppose this one, too.
Read the rest of this commentary.
While the federal government pulls back from global efforts to reduce greenhouse gas pollution, the New England states are considering more aggressive curbs on power plant carbon emissions.
The Regional Greenhouse Gas Initiative, or RGGI, is a market-based cap-and-trade program that sets limits on carbon-dioxide emissions in nine states, including all of New England. Power generators can buy and sell emission allowances under the program — which can give a financial boost to cleaner sources such as wind or hydro plants. So far RGGI’s allowance auctions have raised more than $2.5 billion, with the proceeds flowing to the states, and most of them investing heavily in energy efficiency efforts.
“All the evidence points to the fact that RGGI’s working well, it’s been a great success since its inception,” says Peter Shattuck, director of the Clean Energy Initiative at the Acadia Center, an an environmental policy group with offices in Maine and around the northeast.
“[Since RGGI’s 2009 startup] carbon pollution is down 40 percent, electricity prices are down 3 percent, and at the same time [the participating] states’ economies have grown by 25 percent,” he says.
Read and listen to the rest of this story.
Maine doctors are prescribing far fewer opioids to patients compared with several years ago, a trend that experts say bodes well for future alleviation of the opioid crisis.
However, it’s unknown how long it will take for the decline to have an impact on addiction rates and deaths, and the prescribing rates vary widely, with two of Maine’s 16 counties actually seeing an increase.
The prescribing trends are captured in two reports – a county-level analysis published last week by the U.S. Centers for Disease Control and Prevention, and a national report with state-level data prepared in the spring by a Connecticut health consulting company, QuintilesIMS.
The Quintiles report, done for the American Medical Association, showed that the number of opioid prescriptions in Maine fell 21.5 percent from 2013 to 2016. That’s the fourth-highest drop in the nation, which averaged a 14.6 percent reduction in the same period. Maine’s 0.7 per-capita opioid prescription rate now matches the national average.
Read the rest of the story.